Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Frank Sieg is active.

Publication


Featured researches published by Frank Sieg.


Journal of the Neurological Sciences | 2009

NNZ-2566: A Gly–Pro–Glu analogue with neuroprotective efficacy in a rat model of acute focal stroke

Michael J. Bickerdike; Gregory Brian Thomas; David Charles Batchelor; Ernest Stephen Sirimanne; Wing Leong; Hai Lin; Frank Sieg; Jingyuan Wen; Margaret A. Brimble; Paul W. R. Harris; Peter David Gluckman

The N-terminal cleavage product of human insulin-like growth factor-1 (IGF-1) in the brain is the tripeptide molecule Glypromate (Gly-Pro-Glu). Glypromate has demonstrated neuroprotective effects in numerous in vitro and in vivo models of brain injury and is in clinical trials for the prevention of cognitive impairment following cardiac surgery. NNZ-2566 is a structural analogue of Glypromate, resulting from alpha-methylation of the proline moiety, which has improved the elimination half-life and oral bioavailability over the parent peptide. In vivo, NNZ-2566 reduces injury size in rats subjected to focal stroke. An intravenous infusion of NNZ-2566 of 4 h duration (3-10 mg/kg/h), initiated 3 h after endothelin-induced middle-cerebral artery constriction, significantly reduced infarct area as assessed on day 5. Neuroprotective efficacy in the MCAO model was also observed following oral administration of the drug (30-60 mg/kg), when formulated as a microemulsion. In vitro, NNZ-2566 significantly attenuates apoptotic cell death in primary striatal cultures, suggesting attenuation of apoptosis is one mechanism of action underlying its neuroprotective effects. NNZ-2566 is currently in clinical trials for the treatment of cognitive deficits following traumatic brain injury, and these data further support the development of the drug as a neuroprotective agent for acute brain injury.


Reproductive Biomedicine Online | 2010

Regulation of trophoblast migration and survival by a novel neural regeneration peptide

Ambika T. Singh; Jeffrey A. Keelan; Frank Sieg

Although placental trophoblast migration is tightly controlled in an autocrine/paracrine manner, the nature of chemoattractive factors facilitating and directing this biological activity remains largely elusive. Neural regeneration peptides (NRP), a recently discovered peptide family, stimulate neuronal migration, differentiation and survival of post-natal neurons within the murine central nervous system. Based on the neural-repair related activities of these peptides and parallels between neuronal and placental cell behaviour patterns, this study postulated that they play a role in placental development, in particular trophoblast migration and survival and investigated the role of a newly discovered NRP motif (NNZ-4920), which exhibits about 70% homology to the mouse NRP motif sequence and is homologous to a 13-mer fragment within the N-terminus of human CAPS2, in trophoblast migration and survival regulation. NNZ-4920 significantly enhanced trophoblast migration by 51% (P<0.01) compared with controls and protected against stress induced by serum withdrawal and tumour necrosis factor-alpha/interferon-gamma treatment, at femtomolar concentrations, with efficacy similar to epidermal growth factor. CAPS2 expression was detected in purified term trophoblast and decidual cells. In conclusion, the placenta may be a source of NRP-related gene expression. Its encoded peptide products exert biological effects on term trophoblast migration and survival in vitro.


Archive | 2002

Neural regeneration peptides and methods for their use in treatment of brain damage

Frank Sieg; Paul Hughes; Thorsten Gorba


Atla-alternatives To Laboratory Animals | 2002

Organotypic brain-slice cultures from adult rats: approaches for a prolonged culture time.

Eckbert Wilhelmi; Ulrich H. Schöder; Akilah Benabdallah; Frank Sieg; Jörg Breder; Klaus G. Reymann


Bioorganic & Medicinal Chemistry | 2005

Synthesis and neuroprotective activity of analogues of glycyl-l-prolyl-l-glutamic acid (GPE) modified at the α-carboxylic acid

Nicholas S. Trotter; Margaret A. Brimble; Paul W. R. Harris; David J. Callis; Frank Sieg


Bioorganic & Medicinal Chemistry | 2005

Synthesis and pharmacological evaluation of glycine-modified analogues of the neuroprotective agent glycyl-l-prolyl-l-glutamic acid (GPE)

Michelle Y.H. Lai; Margaret A. Brimble; David J. Callis; Paul W. R. Harris; Mark S. Levi; Frank Sieg


Archive | 2006

Analogs of glycyl-prolyl-glutamate

Margaret A. Brimble; Paul William Richard Harris; Frank Sieg


Experimental Cell Research | 2006

Neural regeneration protein is a novel chemoattractive and neuronal survival-promoting factor

T. Gorba; Privahini Bradoo; Ana Antonic; Keith Marvin; Dong-Xu Liu; Peter E. Lobie; Klaus G. Reymann; Peter D. Gluckman; Frank Sieg


Archive | 2004

Neuroprotective bicyclic compounds and methods for their use

Margaret A. Brimble; Jian Guan; Frank Sieg


Archive | 2005

Effects of glycyl-2 methyl prolyl glutamate on neurodegeneration

Peter D. Gluckman; Gregory Brian Thomas; Jian Guan; M. Dragunow; Ashmit Kumar Anand; Frank Sieg; Margaret A. Brimble

Collaboration


Dive into the Frank Sieg's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jian Guan

University of Auckland

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Klaus G. Reymann

Leibniz Institute for Neurobiology

View shared research outputs
Top Co-Authors

Avatar

Dong-Xu Liu

University of Auckland

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge